METHOD FOR DETECTING A MUTATION INVOLVED IN ALZHEIMER'S DISEASE AND NUCLEOTIDE SEQUENCES FOR IMPLEMENTING SAME

Method for detecting, in a DNA preparation, a mutation involved in Alzheimer's disease, by determining the presence, in the apolipoprotein E gene, of one of the following nucleotide sequences, designated as SEQ ID N DEG 1, SEQ ID N DEG 3 and SEQ ID N DEG 5: SEQ ID N DEG 1: TGC GGC CGC; SEQ ID N...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LUCOTTE, GERARD, REVEILLEAU, STEPHANE
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Method for detecting, in a DNA preparation, a mutation involved in Alzheimer's disease, by determining the presence, in the apolipoprotein E gene, of one of the following nucleotide sequences, designated as SEQ ID N DEG 1, SEQ ID N DEG 3 and SEQ ID N DEG 5: SEQ ID N DEG 1: TGC GGC CGC; SEQ ID N DEG 3: TGC GAC CGC; SEQ ID N DEG 5: CGC GAC CGC. The determination is achieved by polymerase chain reaction (PCR) or sequencing techniques. Procédé de détection, dans une préparation d'ADN, d'une mutation intervenant dans la maladie d'Alzheimer caractérisé en ce que l'on détermine la présence, dans le gène de l'apolipoprotéine E, d'une des séquences nucléotidiques SEQ ID N DEG 1, SEQ ID N DEG 3 ou SEQ ID N DEG 5 suivantes: SEQ ID N DEG 1: TGC GGC CGC; SEQ ID N DEG 3: TGC GAC CGC; SEQ ID N DEG 5: CGC GAC CGC. Cette détermination peut être effectuée par amplification en chaîne par polymérase (PCR) ou par séquençage.